1. Home
  2. IBRX vs AKR Comparison

IBRX vs AKR Comparison

Compare IBRX & AKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ImmunityBio Inc.

IBRX

ImmunityBio Inc.

HOLD

Current Price

$6.23

Market Cap

2.6B

Sector

Health Care

ML Signal

HOLD

Logo Acadia Realty Trust

AKR

Acadia Realty Trust

HOLD

Current Price

$19.91

Market Cap

2.7B

Sector

Real Estate

ML Signal

HOLD

Company Overview

Basic Information
Metric
IBRX
AKR
Founded
2014
1993
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Real Estate Investment Trusts
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
2.6B
2.7B
IPO Year
N/A
1993

Fundamental Metrics

Financial Performance
Metric
IBRX
AKR
Price
$6.23
$19.91
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
3
Target Price
$11.80
$22.00
AVG Volume (30 Days)
46.1M
1.5M
Earning Date
03-02-2026
02-10-2026
Dividend Yield
N/A
4.00%
EPS Growth
N/A
18.54
EPS
N/A
0.12
Revenue
$82,555,000.00
$389,489,000.00
Revenue This Year
$680.06
N/A
Revenue Next Year
$90.18
$16.18
P/E Ratio
N/A
$161.91
Revenue Growth
1025.95
6.01
52 Week Low
$1.83
$16.98
52 Week High
$8.28
$24.95

Technical Indicators

Market Signals
Indicator
IBRX
AKR
Relative Strength Index (RSI) 75.41 36.71
Support Level $5.71 $19.83
Resistance Level $8.28 $21.01
Average True Range (ATR) 0.67 0.44
MACD 0.42 -0.14
Stochastic Oscillator 67.10 2.84

Price Performance

Historical Comparison
IBRX
AKR

About IBRX ImmunityBio Inc.

ImmunityBio Inc is an integrated clinical-stage biotechnology company discovering, developing, and commercializing next-generation immuno- and cellular therapies that bolster the natural immune system to drive and sustain an immune response. Its platforms for the development of biologic product candidates include (i) antibody-cytokine fusion proteins, (ii) DNA, RNA, and recombinant protein vaccines, and (iii) cell therapies. Its focus includes bladder, lung, and colorectal cancers and GBM and its product candidate Anktiva is an IL-15 superagonist antibody-cytokine fusion protein. It has two geographical segments: the United States and Europe. Key revenue is generated from the United States.

About AKR Acadia Realty Trust

Acadia Realty Trust is a real estate investment trust that specializes in the operation, management, leasing, renovation, and acquisition of shopping centers and mixed-use properties with retail components. The company operates through three segments: Core Portfolio segment consists primarily of high-quality retail properties located primarily in high-barrier-to-entry, densely-populated metropolitan areas with a long-term investment horizon; Investment Management segment holds primarily retail real estate in which the company co-invests with high-quality institutional investors; and Structured Financing segment consists of earnings and expenses related to notes and mortgages receivable Fees earned by the company as the general partner or managing member through Investment Management.

Share on Social Networks: